US expansion Aide Health has recently expanded into the United States through a strategic partnership with Temple Health, signaling an opportunity to target US healthcare systems, healthcare providers and payers with chronic condition management and AI scribing solutions.

Diabetes focus Recent and planned collaborations in diabetes management, including a US launch with Temple Health targeting type 2 diabetes, present a clear entry point for selling integrated digital health tools that support patient self-management and clinician workflows.

AI scribe The Mirror AI-powered scribe and AI summarization tool address concerns about recall and understanding of medical advice, offering a compelling value proposition for patient engagement platforms, primary care networks, and remote patient monitoring programs.

Chronic care niche With a flagship product aiding multiple chronic conditions and research in hypertension, there is an opportunity to upsell to clinics and health systems seeking scalable digital care management, remote monitoring, and outcomes analytics.

Public funding traction Recognition from Innovate UK Biomedical Catalyst and NIHR-funded research demonstrates credibility with funders and potential partners; leverage these ties to pursue grants, pilot programs, and collaborative opportunities with health systems and academic centers.